 | • レポートコード：QAF27797 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のナルトレキソンHCL市場について種類別（ナルトレキソンHCL、タイプII）、用途別（オピオイド依存、アルコール依存、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ナルトレキソンHCL市場の概要 ・世界の主要地域別ナルトレキソンHCL市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のナルトレキソンHCL市場規模2016-2021：種類別（ナルトレキソンHCL、タイプII） ・世界のナルトレキソンHCL市場予測2012-2027：種類別（ナルトレキソンHCL、タイプII） ・世界のナルトレキソンHCL市場規模2016-2021：用途別（オピオイド依存、アルコール依存、その他） ・世界のナルトレキソンHCL市場予測2012-2027：用途別（オピオイド依存、アルコール依存、その他） ・ナルトレキソンHCLのアメリカ市場規模と予測2016-2021 ・ナルトレキソンHCLのヨーロッパ市場規模と予測2016-2021 ・ナルトレキソンHCLの中国市場規模と予測2016-2021 ・ナルトレキソンHCLの日本市場規模と予測2016-2021 ・ナルトレキソンHCLの東南アジア市場規模と予測2016-2021 ・ナルトレキソンHCLのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Taj Pharmaceuticals、Freedom Pharmaceuticals、Rusan、Sanofi、IVAX、Faran Shimi、Sun Pharma、Noramco、Haida Taicheng） ・ナルトレキソンHCLの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナルトレキソンHCLの市場動向・機会・課題 ・調査の結論 |
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. As a restricted drug, Naltrexone HCL manufacturers are limited. They mainly concentrated in Europe, India, USA and China.
Global naltrexone HCL consumption areas concentrate in Europe, India and USA. Europe is the largest naltrexone HCL consumption area, which took 38.30% in 2015. India also took 21.44% and USA naltrexone HCL consumption took 18.80% of globe.
Market Analysis and Insights: Global Naltrexone HCL Market
The global Naltrexone HCL market was valued at US$ 20 in 2020 and will reach US$ 21 million by the end of 2027, growing at a CAGR of 0.8% during 2022-2027.
Global Naltrexone HCL Scope and Market Size
The global Naltrexone HCL market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Naltrexone HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Naltrexone HCL
Type II
Segment by Application
Opioid Independence
Alcohol Independence
Other
The Naltrexone HCL market is analysed and market size information is provided by regions (countries). Segment by Application, the Naltrexone HCL market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Taj Pharmaceuticals
Freedom Pharmaceuticals
Rusan
Sanofi
IVAX
Faran Shimi
Sun Pharma
Noramco
Haida Taicheng
1 Naltrexone HCL Market Overview
1.1 Naltrexone HCL Product Scope
1.2 Naltrexone HCL Segment by Type
1.2.1 Global Naltrexone HCL Sales by Type (2016 & 2021 & 2027)
1.2.2 Naltrexone HCL
1.2.3
1.3 Naltrexone HCL Segment by Application
1.3.1 Global Naltrexone HCL Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Opioid Independence
1.3.3 Alcohol Independence
1.3.4 Other
1.4 Naltrexone HCL Market Estimates and Forecasts (2016-2027)
1.4.1 Global Naltrexone HCL Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Naltrexone HCL Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Naltrexone HCL Price Trends (2016-2027)
2 Naltrexone HCL Estimates and Forecasts by Region
2.1 Global Naltrexone HCL Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Naltrexone HCL Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Naltrexone HCL Sales Market Share by Region (2016-2021)
2.2.2 Global Naltrexone HCL Revenue Market Share by Region (2016-2021)
2.3 Global Naltrexone HCL Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Naltrexone HCL Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Naltrexone HCL Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Naltrexone HCL Estimates and Projections (2016-2027)
2.4.2 Europe Naltrexone HCL Estimates and Projections (2016-2027)
2.4.3 China Naltrexone HCL Estimates and Projections (2016-2027)
2.4.4 Japan Naltrexone HCL Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Naltrexone HCL Estimates and Projections (2016-2027)
2.4.6 India Naltrexone HCL Estimates and Projections (2016-2027)
3 Global Naltrexone HCL Competition Landscape by Players
3.1 Global Top Naltrexone HCL Players by Sales (2016-2021)
3.2 Global Top Naltrexone HCL Players by Revenue (2016-2021)
3.3 Global Naltrexone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Naltrexone HCL as of 2020)
3.4 Global Naltrexone HCL Average Price by Company (2016-2021)
3.5 Manufacturers Naltrexone HCL Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Naltrexone HCL Market Size by Type
4.1 Global Naltrexone HCL Historic Market Review by Type (2016-2021)
4.1.1 Global Naltrexone HCL Sales Market Share by Type (2016-2021)
4.1.2 Global Naltrexone HCL Revenue Market Share by Type (2016-2021)
4.1.3 Global Naltrexone HCL Price by Type (2016-2021)
4.2 Global Naltrexone HCL Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Naltrexone HCL Sales Forecast by Type (2022-2027)
4.2.2 Global Naltrexone HCL Revenue Forecast by Type (2022-2027)
4.2.3 Global Naltrexone HCL Price Forecast by Type (2022-2027)
5 Global Naltrexone HCL Market Size by Application
5.1 Global Naltrexone HCL Historic Market Review by Application (2016-2021)
5.1.1 Global Naltrexone HCL Sales Market Share by Application (2016-2021)
5.1.2 Global Naltrexone HCL Revenue Market Share by Application (2016-2021)
5.1.3 Global Naltrexone HCL Price by Application (2016-2021)
5.2 Global Naltrexone HCL Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Naltrexone HCL Sales Forecast by Application (2022-2027)
5.2.2 Global Naltrexone HCL Revenue Forecast by Application (2022-2027)
5.2.3 Global Naltrexone HCL Price Forecast by Application (2022-2027)
6 North America Naltrexone HCL Market Facts & Figures
6.1 North America Naltrexone HCL Sales by Company
6.1.1 North America Naltrexone HCL Sales by Company (2016-2021)
6.1.2 North America Naltrexone HCL Revenue by Company (2016-2021)
6.2 North America Naltrexone HCL Sales Breakdown by Type
6.2.1 North America Naltrexone HCL Sales Breakdown by Type (2016-2021)
6.2.2 North America Naltrexone HCL Sales Breakdown by Type (2022-2027)
6.3 North America Naltrexone HCL Sales Breakdown by Application
6.3.1 North America Naltrexone HCL Sales Breakdown by Application (2016-2021)
6.3.2 North America Naltrexone HCL Sales Breakdown by Application (2022-2027)
7 Europe Naltrexone HCL Market Facts & Figures
7.1 Europe Naltrexone HCL Sales by Company
7.1.1 Europe Naltrexone HCL Sales by Company (2016-2021)
7.1.2 Europe Naltrexone HCL Revenue by Company (2016-2021)
7.2 Europe Naltrexone HCL Sales Breakdown by Type
7.2.1 Europe Naltrexone HCL Sales Breakdown by Type (2016-2021)
7.2.2 Europe Naltrexone HCL Sales Breakdown by Type (2022-2027)
7.3 Europe Naltrexone HCL Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Naltrexone HCL Market Facts & Figures
8.1 China Naltrexone HCL Sales by Company
8.1.1 China Naltrexone HCL Sales by Company (2016-2021)
8.1.2 China Naltrexone HCL Revenue by Company (2016-2021)
8.2 China Naltrexone HCL Sales Breakdown by Type
8.2.1 China Naltrexone HCL Sales Breakdown by Type (2016-2021)
8.2.2 China Naltrexone HCL Sales Breakdown by Type (2022-2027)
8.3 China Naltrexone HCL Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan Naltrexone HCL Market Facts & Figures
9.1 Japan Naltrexone HCL Sales by Company
9.1.1 Japan Naltrexone HCL Sales by Company (2016-2021)
9.1.2 Japan Naltrexone HCL Revenue by Company (2016-2021)
9.2 Japan Naltrexone HCL Sales Breakdown by Type
9.2.1 Japan Naltrexone HCL Sales Breakdown by Type (2016-2021)
9.2.2 Japan Naltrexone HCL Sales Breakdown by Type (2022-2027)
9.3 Japan Naltrexone HCL Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Naltrexone HCL Market Facts & Figures
10.1 Southeast Asia Naltrexone HCL Sales by Company
10.1.1 Southeast Asia Naltrexone HCL Sales by Company (2016-2021)
10.1.2 Southeast Asia Naltrexone HCL Revenue by Company (2016-2021)
10.2 Southeast Asia Naltrexone HCL Sales Breakdown by Type
10.2.1 Southeast Asia Naltrexone HCL Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Naltrexone HCL Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Naltrexone HCL Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Naltrexone HCL Market Facts & Figures
11.1 India Naltrexone HCL Sales by Company
11.1.1 India Naltrexone HCL Sales by Company (2016-2021)
11.1.2 India Naltrexone HCL Revenue by Company (2016-2021)
11.2 India Naltrexone HCL Sales Breakdown by Type
11.2.1 India Naltrexone HCL Sales Breakdown by Type (2016-2021)
11.2.2 India Naltrexone HCL Sales Breakdown by Type (2022-2027)
11.3 India Naltrexone HCL Sales Breakdown by Application
11.3.1 India Naltrexone HCL Sales Breakdown by Application (2016-2021)
11.3.2 India Naltrexone HCL Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Naltrexone HCL Business
12.1 Taj Pharmaceuticals
12.1.1 Taj Pharmaceuticals Corporation Information
12.1.2 Taj Pharmaceuticals Business Overview
12.1.3 Taj Pharmaceuticals Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Taj Pharmaceuticals Naltrexone HCL Products Offered
12.1.5 Taj Pharmaceuticals Recent Development
12.2 Freedom Pharmaceuticals
12.2.1 Freedom Pharmaceuticals Corporation Information
12.2.2 Freedom Pharmaceuticals Business Overview
12.2.3 Freedom Pharmaceuticals Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Freedom Pharmaceuticals Naltrexone HCL Products Offered
12.2.5 Freedom Pharmaceuticals Recent Development
12.3 Rusan
12.3.1 Rusan Corporation Information
12.3.2 Rusan Business Overview
12.3.3 Rusan Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Rusan Naltrexone HCL Products Offered
12.3.5 Rusan Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Naltrexone HCL Products Offered
12.4.5 Sanofi Recent Development
12.5 IVAX
12.5.1 IVAX Corporation Information
12.5.2 IVAX Business Overview
12.5.3 IVAX Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.5.4 IVAX Naltrexone HCL Products Offered
12.5.5 IVAX Recent Development
12.6 Faran Shimi
12.6.1 Faran Shimi Corporation Information
12.6.2 Faran Shimi Business Overview
12.6.3 Faran Shimi Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Faran Shimi Naltrexone HCL Products Offered
12.6.5 Faran Shimi Recent Development
12.7 Sun Pharma
12.7.1 Sun Pharma Corporation Information
12.7.2 Sun Pharma Business Overview
12.7.3 Sun Pharma Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharma Naltrexone HCL Products Offered
12.7.5 Sun Pharma Recent Development
12.8 Noramco
12.8.1 Noramco Corporation Information
12.8.2 Noramco Business Overview
12.8.3 Noramco Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Noramco Naltrexone HCL Products Offered
12.8.5 Noramco Recent Development
12.9 Haida Taicheng
12.9.1 Haida Taicheng Corporation Information
12.9.2 Haida Taicheng Business Overview
12.9.3 Haida Taicheng Naltrexone HCL Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Haida Taicheng Naltrexone HCL Products Offered
12.9.5 Haida Taicheng Recent Development
13 Naltrexone HCL Manufacturing Cost Analysis
13.1 Naltrexone HCL Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Naltrexone HCL
13.4 Naltrexone HCL Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Naltrexone HCL Distributors List
14.3 Naltrexone HCL Customers
15 Market Dynamics
15.1 Naltrexone HCL Market Trends
15.2 Naltrexone HCL Drivers
15.3 Naltrexone HCL Market Challenges
15.4 Naltrexone HCL Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Naltrexone HCL Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Naltrexone HCL Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Naltrexone HCL Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Naltrexone HCL Sales (Kg) by Region (2016-2021)
Table 5. Global Naltrexone HCL Sales Market Share by Region (2016-2021)
Table 6. Global Naltrexone HCL Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Naltrexone HCL Revenue Share by Region (2016-2021)
Table 8. Global Naltrexone HCL Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Naltrexone HCL Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Naltrexone HCL Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Naltrexone HCL Revenue Share Forecast by Region (2022-2027)
Table 12. Global Naltrexone HCL Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Naltrexone HCL Sales Share by Company (2016-2021)
Table 14. Global Naltrexone HCL Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Naltrexone HCL Revenue Share by Company (2016-2021)
Table 16. Global Naltrexone HCL by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Naltrexone HCL as of 2020)
Table 17. Global Naltrexone HCL Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Naltrexone HCL Manufacturing Sites and Area Served
Table 19. Manufacturers Naltrexone HCL Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Naltrexone HCL Sales (Kg) by Type (2016-2021)
Table 22. Global Naltrexone HCL Sales Share by Type (2016-2021)
Table 23. Global Naltrexone HCL Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Naltrexone HCL Price (USD/Kg) by Type (2016-2021)
Table 25. Global Naltrexone HCL Sales Share by Type (2022-2027)
Table 26. Global Naltrexone HCL Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Naltrexone HCL Revenue Share by Type (2022-2027)
Table 28. Global Naltrexone HCL Price (USD/Kg) by Type (2022-2027)
Table 29. Global Naltrexone HCL Sales (Kg) by Application (2016-2021)
Table 30. Global Naltrexone HCL Sales Share by Application (2016-2021)
Table 31. Global Naltrexone HCL Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Naltrexone HCL Price (USD/Kg) by Application (2016-2021)
Table 33. Global Naltrexone HCL Sales (Kg) by Application (2022-2027)
Table 34. Global Naltrexone HCL Sales Share by Application (2022-2027)
Table 35. Global Naltrexone HCL Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Naltrexone HCL Revenue Share by Application (2022-2027)
Table 37. Global Naltrexone HCL Price (USD/Kg) by Application (2022-2027)
Table 38. North America Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 39. North America Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 40. North America Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 42. North America Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 43. North America Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 44. North America Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 45. North America Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 46. North America Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 47. North America Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 48. North America Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 49. North America Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 50. Europe Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 51. Europe Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 52. Europe Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 54. Europe Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 55. Europe Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 56. Europe Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 57. Europe Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 58. Europe Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 59. Europe Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 60. Europe Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 61. Europe Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 62. China Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 63. China Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 64. China Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 66. China Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 67. China Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 68. China Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 69. China Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 70. China Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 71. China Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 72. China Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 73. China Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 74. Japan Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 75. Japan Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 76. Japan Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 78. Japan Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 79. Japan Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 80. Japan Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 81. Japan Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 82. Japan Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 83. Japan Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 84. Japan Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 85. Japan Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 98. India Naltrexone HCL Sales (Kg) by Company (2016-2021)
Table 99. India Naltrexone HCL Sales Market Share by Company (2016-2021)
Table 100. India Naltrexone HCL Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Naltrexone HCL Revenue Market Share by Company (2016-2021)
Table 102. India Naltrexone HCL Sales by Type (2016-2021) & (Kg)
Table 103. India Naltrexone HCL Sales Market Share by Type (2016-2021)
Table 104. India Naltrexone HCL Sales by Type (2022-2027) & (Kg)
Table 105. India Naltrexone HCL Sales Market Share by Type (2022-2027)
Table 106. India Naltrexone HCL Sales by Application (2016-2021) & (Kg)
Table 107. India Naltrexone HCL Sales Market Share by Application (2016-2021)
Table 108. India Naltrexone HCL Sales by Application (2022-2027) & (Kg)
Table 109. India Naltrexone HCL Sales Market Share by Application (2022-2027)
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Taj Pharmaceuticals Naltrexone HCL Product
Table 114. Taj Pharmaceuticals Recent Development
Table 115. Freedom Pharmaceuticals Corporation Information
Table 116. Freedom Pharmaceuticals Description and Business Overview
Table 117. Freedom Pharmaceuticals Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Freedom Pharmaceuticals Naltrexone HCL Product
Table 119. Freedom Pharmaceuticals Recent Development
Table 120. Rusan Corporation Information
Table 121. Rusan Description and Business Overview
Table 122. Rusan Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Rusan Naltrexone HCL Product
Table 124. Rusan Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Sanofi Naltrexone HCL Product
Table 129. Sanofi Recent Development
Table 130. IVAX Corporation Information
Table 131. IVAX Description and Business Overview
Table 132. IVAX Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. IVAX Naltrexone HCL Product
Table 134. IVAX Recent Development
Table 135. Faran Shimi Corporation Information
Table 136. Faran Shimi Description and Business Overview
Table 137. Faran Shimi Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Faran Shimi Naltrexone HCL Product
Table 139. Faran Shimi Recent Development
Table 140. Sun Pharma Corporation Information
Table 141. Sun Pharma Description and Business Overview
Table 142. Sun Pharma Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Sun Pharma Naltrexone HCL Product
Table 144. Sun Pharma Recent Development
Table 145. Noramco Corporation Information
Table 146. Noramco Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Noramco Description and Business Overview
Table 148. Noramco Naltrexone HCL Product
Table 149. Noramco Recent Development
Table 150. Haida Taicheng Corporation Information
Table 151. Haida Taicheng Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Haida Taicheng Description and Business Overview
Table 153. Haida Taicheng Naltrexone HCL Product
Table 154. Haida Taicheng Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Naltrexone HCL Distributors List
Table 158. Naltrexone HCL Customers List
Table 159. Naltrexone HCL Market Trends
Table 160. Naltrexone HCL Market Drivers
Table 161. Naltrexone HCL Market Challenges
Table 162. Naltrexone HCL Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Naltrexone HCL Product Picture
Figure 2. Global Naltrexone HCL Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Naltrexone HCL Sales Market Share by Application in 2021 & 2027
Figure 6. Opioid Independence Examples
Figure 7. Alcohol Independence Examples
Figure 8. Other Examples
Figure 9. Global Naltrexone HCL Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Naltrexone HCL Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Naltrexone HCL Sales (Kg) Growth Rate (2016-2027)
Figure 12. Global Naltrexone HCL Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 13. Global Naltrexone HCL Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Naltrexone HCL Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Naltrexone HCL Sales (Kg) Growth Rate (2016-2027)
Figure 17. Europe Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Naltrexone HCL Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Naltrexone HCL Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Naltrexone HCL Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Naltrexone HCL Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Naltrexone HCL Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Naltrexone HCL Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Naltrexone HCL Players Market Share by Revenue in Naltrexone HCL: 2016 & 2020
Figure 28. Naltrexone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Naltrexone HCL Revenue Share by Type (2016-2021)
Figure 30. Global Naltrexone HCL Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Naltrexone HCL Revenue Share by Application (2016-2021)
Figure 32. Global Naltrexone HCL Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Naltrexone HCL Sales Market Share by Type in 2020
Figure 34. North America Naltrexone HCL Sales Market Share by Application in 2020
Figure 35. Europe Naltrexone HCL Sales Market Share by Type in 2020
Figure 36. Europe Naltrexone HCL Sales Market Share by Application in 2020
Figure 37. China Naltrexone HCL Sales Market Share by Type in 2020
Figure 38. China Naltrexone HCL Sales Market Share by Application in 2020
Figure 39. Japan Naltrexone HCL Sales Market Share by Type in 2020
Figure 40. Japan Naltrexone HCL Sales Market Share by Application in 2020
Figure 41. Southeast Asia Naltrexone HCL Sales Market Share by Type in 2020
Figure 42. Southeast Asia Naltrexone HCL Sales Market Share by Application in 2020
Figure 43. India Naltrexone HCL Sales Market Share by Type in 2020
Figure 44. India Naltrexone HCL Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Naltrexone HCL
Figure 47. Manufacturing Process Analysis of Naltrexone HCL
Figure 48. Naltrexone HCL Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年） An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress. Increase in opioid epidemic in the U.S. coupled with establishment of government poli…- オピオイド誘発性便秘症のグローバル市場2021 Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives. In the last several years, global market …
- イソトリデシルアルコール（ITDA）のグローバル市場2021 ITDA is a high-quality intermediate for the versatile and safe usage in the manufacturing of surfactants. Isotridecyl Alcohol (ITDA)’s industry concentration degree is highly concentrated, only a few enterprises master the production technology, with the trend of monopoly. The main manufacturers are…
- アルコールデヒドロゲナーゼのグローバル市場2021 Alcohol dehydrogenase (ADH), part of the oxidoreductase family, catalyzes the oxidation of alcohols, using NAD+ or NADP+ as the electron acceptor (White and White 1997). The reaction is reversible and substrates can be a variety of primary or secondary alcohols, and hemiacetals. Alcohol dehydrogenas…
- 世界のオピオイド薬市場規模・現状・予測（2021年-2027年） Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect. Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons…